Inventiva SA (IVAA)

Paris
Currency in EUR
2.76
-0.05(-1.61%)
Real-time Data·
IVAA Scorecard
Full Analysis
Impressive gross profit margins
Earnings results expected today
Fair Value
Day's Range
2.752.81
52 wk Range
1.433.50
Key Statistics
Edit
Prev. Close
2.8
Open
2.81
Day's Range
2.75-2.81
52 wk Range
1.43-3.5
Volume
9.87K
Average Volume (3m)
41.79K
1-Year Change
-14.63%
Book Value / Share
-1.11
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IVAA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.30
Upside
+128.26%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Inventiva Company Profile

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of MASH and other diseases in France, the United States, and Internationally. It develops Lanifibranor, for the treatment of patients with metabolic dysfunction-associated steatohepatitis, a progressive, chronic liver disease, which is in Phase III clinical trial; and Odiparcil for the treatment of patients with mucopolysaccharidoses, or MPS, a group of rare genetic disorders characterized by an excessive accumulation of large sugar chains, known as glycosaminoglycans, or GAGs, in cells. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was incorporated in 2011 and is headquartered in Daix, France.

Employees
116
Market
France

Compare IVAA to Peers and Sector

Metrics to compare
IVAA
Peers
Sector
Relationship
P/E Ratio
−2.1x−2.3x−0.4x
PEG Ratio
0.080.040.00
Price/Book
−3.6x2.2x2.6x
Price / LTM Sales
27.2x9.8x2.9x
Upside (Analyst Target)
139.3%216.3%53.5%
Fair Value Upside
Unlock7.8%9.5%Unlock

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 6.30
(+128.26% Upside)

Earnings

Latest Release
Mar 26, 2025
EPS / Forecast
-1.68 / -0.4091
Revenue / Forecast
11.97M / 1.43M
EPS Revisions
Last 90 days

FAQ

What Is the Inventiva (IVAA) Stock Price Today?

The Inventiva stock price today is 2.76.

What Stock Exchange Does Inventiva Trade On?

Inventiva is listed and trades on the Paris Stock Exchange stock exchange.

What Is the Stock Symbol for Inventiva?

The stock symbol for Inventiva is "IVAA."

What Is the Inventiva Market Cap?

As of today, Inventiva market cap is 385.45M.

What Is Inventiva's Earnings Per Share (TTM)?

The Inventiva EPS (TTM) is -3.08.

When Is the Next Inventiva Earnings Date?

Inventiva will release its next earnings report on 22 May 2025.

From a Technical Analysis Perspective, Is IVAA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Inventiva Stock Split?

Inventiva has split 0 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.